RAB32 Promotes Glioma Cell Progression by Activating the JAK/STAT3 Signaling Pathway

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2024 Dec 4

PMID 39628429

Authors

Sinan Zhang

Xudong Jiang

Qing Wei

Liji Huang

Zhuoyan Huang

Lina Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to investigate the role of RAB32 in glioblastomas and its molecular mechanisms that regulate gliomas.

Methods: The expression and prognostic value of RAB32 were evaluated using western blotting and the Gene Expression Profiling Interactive, Chinese Glioma Genome Atlas, and The Cancer Genome Atlas databases. Lentivirus containing sh-RAB32 or OE-RAB32 was used to manipulate RAB32 expression in glioma cells. The effects of RAB32 on cell proliferation, migration, and invasion were determined by western blotting, cell counting kit-8, plate cloning, wound healing, and transwell assays. Gene set enrichment analysis was used to screen for associations between the JAK/STAT3 signaling pathway and RAB32. The role of this pathway was verified using JAK/STAT3 inhibitors.

Results: RAB32 expression was significantly upregulated in patients with glioma and in glioma cell lines. The expression level was positively correlated with the glioma grade and served as an independent prognostic factor. In vitro experiments revealed that RAB32 knockdown inhibited glioblastoma cell proliferation, migration, and invasion, while the opposite effects were observed with overexpression and could be inhibited by the JAK/STAT3 inhibitor BP-1-102.

Conclusion: RAB32 promotes malignant progression of glioblastoma cells through the JAK/STAT signaling pathway, providing new possibilities for therapeutic targets for glioblastoma.

References

Pylypenko O, Hammich H, Yu I, Houdusse A . Rab GTPases and their interacting protein partners: Structural insights into Rab functional diversity. Small GTPases. 2017; 9(1-2):22-48. PMC: 5902227. DOI: 10.1080/21541248.2017.1336191. View

Liang B, Li S, Gong H, Wang L, Lu J, Zhao Y . Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma. Dis Markers. 2020; 2020:8833885. PMC: 7704152. DOI: 10.1155/2020/8833885. View

Xie X, Ni Q, Zhou D, Wan Y . Rab32-related antimicrobial pathway is involved in the progression of dextran sodium sulfate-induced colitis. FEBS Open Bio. 2018; 8(10):1658-1668. PMC: 6168699. DOI: 10.1002/2211-5463.12514. View

Zhu H, Hu X, Gu L, Jian Z, Li L, Hu S . TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment. Front Genet. 2021; 12:759953. PMC: 8553001. DOI: 10.3389/fgene.2021.759953. View

Rong L, Li N, Zhang Z . Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022; 41(1):142. PMC: 9013078. DOI: 10.1186/s13046-022-02349-7. View

Jang Y, Baik E . JAK-STAT pathway and myogenic differentiation. JAKSTAT. 2013; 2(2):e23282. PMC: 3710318. DOI: 10.4161/jkst.23282. View

Zhang Y, Zhou M, Li K . MicroRNA-30 inhibits the growth of human ovarian cancer cells by suppressing RAB32 expression. Int J Immunopathol Pharmacol. 2022; 36:20587384211058642. PMC: 8744078. DOI: 10.1177/20587384211058642. View

Thomas S, Snowden J, Zeidler M, Danson S . The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015; 113(3):365-71. PMC: 4522639. DOI: 10.1038/bjc.2015.233. View

Bultema J, Ambrosio A, Burek C, Di Pietro S . BLOC-2, AP-3, and AP-1 proteins function in concert with Rab38 and Rab32 proteins to mediate protein trafficking to lysosome-related organelles. J Biol Chem. 2012; 287(23):19550-63. PMC: 3365991. DOI: 10.1074/jbc.M112.351908. View

10.

Herrera S, Bach E . JAK/STAT signaling in stem cells and regeneration: from to vertebrates. Development. 2019; 146(2). PMC: 6361132. DOI: 10.1242/dev.167643. View

11.

Stenmark H . Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009; 10(8):513-25. DOI: 10.1038/nrm2728. View

12.

Tu Y, Zhong Y, Fu J, Cao Y, Fu G, Tian X . Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas. Med Oncol. 2010; 28(1):15-23. DOI: 10.1007/s12032-010-9435-1. View

13.

Hirota Y, Tanaka Y . A small GTPase, human Rab32, is required for the formation of autophagic vacuoles under basal conditions. Cell Mol Life Sci. 2009; 66(17):2913-32. PMC: 11115675. DOI: 10.1007/s00018-009-0080-9. View

14.

Sansone P, Bromberg J . Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 2012; 30(9):1005-14. PMC: 3341105. DOI: 10.1200/JCO.2010.31.8907. View

15.

Pereira-Leal J, Seabra M . Evolution of the Rab family of small GTP-binding proteins. J Mol Biol. 2001; 313(4):889-901. DOI: 10.1006/jmbi.2001.5072. View

16.

Ostrom Q, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan J . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. Neuro Oncol. 2021; 23(12 Suppl 2):iii1-iii105. PMC: 8491279. DOI: 10.1093/neuonc/noab200. View

17.

Janjua T, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld F, Kulshreshtha R . Frontiers in the treatment of glioblastoma: Past, present and emerging. Adv Drug Deliv Rev. 2021; 171:108-138. DOI: 10.1016/j.addr.2021.01.012. View

18.

Reifenberger G, Wirsching H, Knobbe-Thomsen C, Weller M . Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol. 2016; 14(7):434-452. DOI: 10.1038/nrclinonc.2016.204. View

19.

Li J, Wang X, Chen L, Zhang J, Zhang Y, Ren X . TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas. Cancer Gene Ther. 2022; 29(8-9):1117-1129. PMC: 9395270. DOI: 10.1038/s41417-021-00414-5. View

20.

Khasraw M, Lassman A . Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nat Rev Neurol. 2009; 5(12):646-7. DOI: 10.1038/nrneurol.2009.194. View